L. O’Toole

发表

Management of solitary brain metastases.

N. Charnley, G. Gerrard, L. O’Toole, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Strengthening clinical cancer research in the United Kingdom

R. B. Hamilton, M. Parmar, D. Stewart, 2011, British Journal of Cancer.

Should we routinely offer a second admission for radioiodine to patients with high-risk differentiated thyroid cancer?

F. Roberts, G. Gerrard, L. O’Toole, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic

S. Bhide, S. Schipani, A. Michaelidou, 2021, Clinical and Translational Radiation Oncology.

Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study

R. Thomas, I. Nagtegaal, D. Tait, 2022, Annals of Surgical Oncology.

Transoral endoscopic base of tongue mucosectomy for investigation of unknown primary cancers of head and neck

J. Jose, L. Karsai, L. O’Toole, 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

C. R. Leemans, C. McConkey, T. Roques, 2019, The Lancet.

Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study.

T. Roques, J. Dunn, H. Mehanna, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Manageable early toxicity of cetuximab concurrent with radical radiotherapy for locally advanced head and neck cancer.

A. Wieczorek, A. Hamid, L. O’Toole, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Electrochemotherapy vs radiotherapy in the treatment of primary cutaneous malignancies or cutaneous metastases from primary solid organ malignancies: a protocol for a systematic review and meta-analysis

Angus E. McMillan, P. Matteucci, J. Totty, 2022, Journal of Surgical Protocols and Research Methodologies.

Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme

Simon C Watkins, S. Ellis, K. Fife, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer ( DeESCALaTE HPV )

C. McConkey, S. Whitaker, J. Buter, 2018 .

Developing a complex intervention for the outpatient management of incidentally diagnosed pulmonary embolism in cancer patients

Miriam J. Johnson, Ged Avery, Lorcan O’Toole, 2013, BMC Health Services Research.

Research-intensive cancer care in the NHS in the UK.

M. Parmar, D. Stewart, R. Wilson, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Head and Neck Cancer

N. Stafford, L. O’Toole, 2020, Treatment of Cancer.

Electrochemotherapy vs radiotherapy in the treatment of primary cutaneous malignancies or cutaneous metastases from primary solid organ malignancies: A systematic review and narrative synthesis

Angus E. McMillan, P. Matteucci, J. Totty, 2023, PloS one.

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy.

A. Gray, J. Buter, J. Dunn, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.